{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-116947","form_type":"8-K","ticker":"GANX","cik":"0001819411","company_name":"Gain Therapeutics, Inc.","filed_at":"2025-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.591449+00:00","generated_at":"2026-05-16T16:14:57.709404+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Gain Therapeutics files prospectus supplement for up to $35.5M ATM stock offering","bullets":["Prospectus supplement filed for ATM offering of up to $35.5M of common stock via Oppenheimer & Co.","Company previously sold $14.47M under prior ATM program dated Sept 2024, now updating under new shelf.","New S-3 registration (333-287622) became effective Nov 26, 2025; supplement dated Nov 28, 2025.","Proceeds expected for general corporate purposes; legal opinion from Lowenstein Sandler attached."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-116947","json":"https://secwatch.observer/filing/0001104659-25-116947.json","markdown":"https://secwatch.observer/filing/0001104659-25-116947.md","text":"https://secwatch.observer/filing/0001104659-25-116947.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819411/000110465925116947/0001104659-25-116947-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819411/000110465925116947/tm2530369d4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:14:57.709404+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}